Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00301366
Status:
COMPLETED
Last Update Posted:
2014-08-19
First Post:
2006-03-08
Brief Title:
The Safety and Tolerability of Alpha-1 Modified Process MP In Subjects With Alpha-1-antitrypsin AAT Deficiency
Sponsor:
Grifols Therapeutics LLC
Organization:
Grifols Therapeutics LLC
Organization Data
Organization:
Grifols Therapeutics LLC
Class:
INDUSTRY
Study ID:
11815
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Grifols Therapeutics LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None